WASATCH ADVISORS INC 13D and 13G filings for C4 Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-22 5:27 pm Sale | 2026-03-31 | 13G | C4 THERAPEUTICS INC CCCC | WASATCH ADVISORS INC | 4,581,761 4.700% | -270,980 (-5.58%) | Filing |
| 2025-11-13 5:33 pm Sale | 2025-09-30 | 13G | C4 THERAPEUTICS INC CCCC | WASATCH ADVISORS INC | 4,852,741 6.800% | -2,620,591 (-35.07%) | Filing |
| 2025-05-07 1:39 pm Purchase | 2025-04-30 | 13G | C4 THERAPEUTICS INC CCCC | WASATCH ADVISORS INC | 7,473,332 10.500% | 1,956,614 (+35.47%) | Filing |
| 2024-03-08 1:11 pm Sale | 2024-03-08 | 13G | C4 THERAPEUTICS INC CCCC | WASATCH ADVISORS INC | 5,516,718 8.000% | -1,622,231 (-22.72%) | Filing |
| 2024-02-09 1:04 pm Purchase | 2024-02-09 | 13G | C4 THERAPEUTICS INC CCCC | WASATCH ADVISORS INC | 7,138,949 14.500% | 1,363,251 (+23.60%) | Filing |
| 2023-02-08 3:42 pm Purchase | 2023-02-08 | 13G | C4 THERAPEUTICS INC CCCC | WASATCH ADVISORS INC | 5,775,698 11.800% | 789,626 (+15.84%) | Filing |
| 2022-06-06 1:31 pm Purchase | 2022-06-06 | 13G | C4 THERAPEUTICS INC CCCC | WASATCH ADVISORS INC | 4,986,072 10.200% | 4,986,072 (New Position) | Filing |